Alfred Horhey

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: Africa

Consulting Services

Admin and Customer Support IT-Web-Mobile Technology Grant Submission

Areas Of Interest

Protein Phosphatase 3 Inhibitors Centers for Medicare and Medicaid Services, U.S. Tissue Inhibitor of Metalloproteinase 1 Pachygyria Fiber, Fast-Twitch Muscle Chemotherapy, Maintenance beta-Crystallin A Chain Umbellatine Children, Homeless Tightness, Muscle Therapies, Early Limonene, (+-)- Physiological Feedback Agnogenic Myeloid Metaplasias beta-Aminoethylisothiuronium Sulfate (1:1) Library Service Lewis Rats, Inbred Receptor, 5 Hydroxytryptamine 1B Maternal Obesity Sugar-Sweetened Sodas Pregnancy Specific beta 1 Glycoproteins Peroxisome Pancornulin, 14.9 kDa Bufal M4 Receptor, Muscarinic Artery, Subclavian Sulfobenzylpenicillin

Professional Narrative

Dr. Alfred Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2005
Executive Director, Harvard Med 2007

Education

Master of Science in physician assistant, Perelman School of Medicine 1993
Director Medicine, Baylor College 2004

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :